These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad. Haller F; Moskalev EA; Faucz FR; Barthelmeß S; Wiemann S; Bieg M; Assie G; Bertherat J; Schaefer IM; Otto C; Rattenberry E; Maher ER; Ströbel P; Werner M; Carney JA; Hartmann A; Stratakis CA; Agaimy A Endocr Relat Cancer; 2014 Aug; 21(4):567-77. PubMed ID: 24859990 [TBL] [Abstract][Full Text] [Related]
12. Urinary Bladder Paragangliomas: How Immunohistochemistry Can Assist to Identify Patients With SDHB Germline and Somatic Mutations. Giubellino A; Lara K; Martucci V; Huynh T; Agarwal P; Pacak K; Merino MJ Am J Surg Pathol; 2015 Nov; 39(11):1488-92. PubMed ID: 26457353 [TBL] [Abstract][Full Text] [Related]
13. Metastatic sympathetic paraganglioma in a patient with loss of the SDHC gene. Rich T; Jackson M; Roman-Gonzalez A; Shah K; Cote GJ; Jimenez C Fam Cancer; 2015 Dec; 14(4):615-9. PubMed ID: 26162468 [TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility. Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914 [TBL] [Abstract][Full Text] [Related]
16. High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. Brouwers FM; Eisenhofer G; Tao JJ; Kant JA; Adams KT; Linehan WM; Pacak K J Clin Endocrinol Metab; 2006 Nov; 91(11):4505-9. PubMed ID: 16912137 [TBL] [Abstract][Full Text] [Related]
17. Identification of three new variants of SDHx genes in a cohort of Portuguese patients with extra-adrenal paragangliomas. Domingues R; Montalvão P; Magalhães M; Santos R; Duarte L; Bugalho MJ J Endocrinol Invest; 2012 Dec; 35(11):975-80. PubMed ID: 22293219 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas. Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Valdés N; Astudillo A; Balbín M; Pitiot AS; Jiménez-Fonseca P; Scola B; Tena I; Molina-Garrido MJ; Sevilla MA; Beristein E; Forga L; Villabona C; Oriola J; Halperin I; Suarez C; Chiara MD Head Neck; 2019 Jan; 41(1):79-91. PubMed ID: 30549360 [TBL] [Abstract][Full Text] [Related]
19. Urinary Bladder Paragangliomas: Analysis of Succinate Dehydrogenase and Outcome. Gupta S; Zhang J; Rivera M; Erickson LA Endocr Pathol; 2016 Sep; 27(3):243-52. PubMed ID: 27262318 [TBL] [Abstract][Full Text] [Related]
20. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. Burnichon N; Rohmer V; Amar L; Herman P; Leboulleux S; Darrouzet V; Niccoli P; Gaillard D; Chabrier G; Chabolle F; Coupier I; Thieblot P; Lecomte P; Bertherat J; Wion-Barbot N; Murat A; Venisse A; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP; J Clin Endocrinol Metab; 2009 Aug; 94(8):2817-27. PubMed ID: 19454582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]